Software - Application
Compare Stocks
5 / 10Stock Comparison
SURG vs LQDT vs RILY vs GSAT vs SPOK
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Financial - Conglomerates
Telecommunications Services
Medical - Healthcare Information Services
SURG vs LQDT vs RILY vs GSAT vs SPOK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Specialty Retail | Financial - Conglomerates | Telecommunications Services | Medical - Healthcare Information Services |
| Market Cap | $11M | $1.12B | $305M | $10.33B | $225M |
| Revenue (TTM) | $50M | $480M | $1.03B | $262M | $103M |
| Net Income (TTM) | $-42M | $30M | $531M | $-50M | $11M |
| Gross Margin | -38.6% | 23.2% | 65.0% | 57.2% | 91.4% |
| Operating Margin | -78.8% | 8.4% | 14.6% | 1.4% | 13.2% |
| Forward P/E | — | 24.3x | 1.1x | — | 16.4x |
| Total Debt | $5M | $14M | $1.47B | $542M | $7M |
| Cash & Equiv. | $12M | $175M | $227M | $391M | $25M |
SURG vs LQDT vs RILY vs GSAT vs SPOK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| Liquidity Services,… (LQDT) | 100 | 634.9 | +534.9% |
| BRC Group Holdings,… (RILY) | 100 | 44.7 | -55.3% |
| Globalstar, Inc. (GSAT) | 100 | 1845.3 | +1745.3% |
| Spok Holdings, Inc. (SPOK) | 100 | 104.1 | +4.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs LQDT vs RILY vs GSAT vs SPOK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SURG doesn't own a clear edge in any measured category.
LQDT ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 31.2%, EPS growth 38.1%, 3Y rev CAGR 19.4%
- 5.1% 10Y total return vs GSAT's 201.8%
- 31.2% revenue growth vs SURG's -55.6%
RILY carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 29.8% margin vs SURG's -83.4%
- 31.3% ROA vs SURG's -242.4%, ROIC 8.3% vs -229.7%
GSAT is the clearest fit if your priority is momentum.
- +305.2% vs SURG's -78.9%
SPOK is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 5 yrs, beta 0.42, yield 11.9%
- Lower volatility, beta 0.42, Low D/E 4.7%, current ratio 1.18x
- Beta 0.42, yield 11.9%, current ratio 1.18x
- Beta 0.42 vs GSAT's 2.08, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.2% revenue growth vs SURG's -55.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 29.8% margin vs SURG's -83.4% | |
| Stability / Safety | Beta 0.42 vs GSAT's 2.08, lower leverage | |
| Dividends | 11.9% yield, 5-year raise streak, vs GSAT's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +305.2% vs SURG's -78.9% | |
| Efficiency (ROA) | 31.3% ROA vs SURG's -242.4%, ROIC 8.3% vs -229.7% |
SURG vs LQDT vs RILY vs GSAT vs SPOK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs LQDT vs RILY vs GSAT vs SPOK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RILY leads in 1 of 6 categories
LQDT leads 1 • GSAT leads 1 • SPOK leads 1 • SURG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RILY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RILY is the larger business by revenue, generating $1.0B annually — 20.5x SURG's $50M. RILY is the more profitable business, keeping 29.8% of every revenue dollar as net income compared to SURG's -83.4%. On growth, SURG holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $480M | $1.0B | $262M | $103M |
| EBITDAEarnings before interest/tax | -$39M | $51M | $390M | $93M | $17M |
| Net IncomeAfter-tax profit | -$42M | $30M | $531M | -$50M | $11M |
| Free Cash FlowCash after capex | -$26M | $78M | $180M | $151M | $26M |
| Gross MarginGross profit ÷ Revenue | -38.6% | +23.2% | +65.0% | +57.2% | +91.4% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +8.4% | +14.6% | +1.4% | +13.2% |
| Net MarginNet income ÷ Revenue | -83.4% | +6.3% | +29.8% | -19.0% | +10.3% |
| FCF MarginFCF ÷ Revenue | -50.9% | +16.2% | -6.9% | +57.6% | +24.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +3.7% | — | +2.1% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | +4.5% | +100.0% | -121.9% | -64.0% |
Valuation Metrics
Evenly matched — SURG and SPOK each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 1.1x trailing earnings, RILY trades at a 97% valuation discount to LQDT's 41.7x P/E. On an enterprise value basis, RILY's 8.3x EV/EBITDA is more attractive than GSAT's 119.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $1.1B | $305M | $10.3B | $225M |
| Enterprise ValueMkt cap + debt − cash | $4M | $964M | $1.5B | $10.5B | $206M |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | 41.67x | 1.14x | -138.10x | 14.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 24.33x | — | — | 16.41x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 21.19x | 8.33x | 119.09x | 8.91x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 2.36x | 0.30x | 41.28x | 1.61x |
| Price / BookPrice ÷ Book value/share | 0.70x | 5.78x | — | 28.58x | 1.56x |
| Price / FCFMarket cap ÷ FCF | — | 19.07x | — | 57.85x | 8.91x |
Profitability & Efficiency
LQDT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LQDT delivers a 14.2% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-10 for SURG. SPOK carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to GSAT's 1.51x. On the Piotroski fundamental quality scale (0–9), LQDT scores 7/9 vs SURG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | +14.2% | — | -13.7% | +7.3% |
| ROA (TTM)Return on assets | -2.4% | +8.0% | +31.3% | -2.3% | +5.2% |
| ROICReturn on invested capital | -2.3% | +60.8% | +8.3% | -0.1% | +11.3% |
| ROCEReturn on capital employed | -177.3% | +17.3% | +10.2% | -0.1% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.30x | 0.07x | — | 1.51x | 0.05x |
| Net DebtTotal debt minus cash | -$7M | -$160M | $1.2B | $151M | -$18M |
| Cash & Equiv.Liquid assets | $12M | $175M | $227M | $391M | $25M |
| Total DebtShort + long-term debt | $5M | $14M | $1.5B | $542M | $7M |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | — | 10.78x | -0.07x | — |
Total Returns (Dividends Reinvested)
GSAT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GSAT five years ago would be worth $49,382 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, GSAT leads with a +305.2% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors GSAT at 80.1% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.4% | +22.5% | +67.8% | +27.3% | -14.3% |
| 1-Year ReturnPast 12 months | -78.9% | +15.0% | +210.4% | +305.2% | -26.7% |
| 3-Year ReturnCumulative with dividends | -86.9% | +157.1% | -65.6% | +484.1% | +13.4% |
| 5-Year ReturnCumulative with dividends | -92.8% | +47.8% | -64.6% | +393.8% | +61.9% |
| 10-Year ReturnCumulative with dividends | -99.1% | +508.2% | +239.7% | +201.8% | +13.3% |
| CAGR (3Y)Annualised 3-year return | -49.3% | +37.0% | -29.9% | +80.1% | +4.3% |
Risk & Volatility
Evenly matched — GSAT and SPOK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than GSAT's 2.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GSAT currently trades 98.3% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.82x | 2.02x | 2.08x | 0.42x |
| 52-Week HighHighest price in past year | $3.45 | $38.83 | $10.97 | $82.85 | $19.31 |
| 52-Week LowLowest price in past year | $0.46 | $21.67 | $2.75 | $17.24 | $9.96 |
| % of 52W HighCurrent price vs 52-week peak | +16.2% | +93.4% | +79.2% | +98.3% | +56.1% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 81.6 | 65.8 | 66.4 | 36.7 |
| Avg Volume (50D)Average daily shares traded | 378K | 159K | 820K | 1.5M | 185K |
Analyst Outlook
SPOK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LQDT as "Buy", RILY as "Hold", GSAT as "Hold", SPOK as "Hold". Consensus price targets imply 38.5% upside for SPOK (target: $15) vs -19.0% for GSAT (target: $66). For income investors, SPOK offers the higher dividend yield at 11.95% vs GSAT's 0.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $44.00 | — | $66.00 | $15.00 |
| # AnalystsCovering analysts | — | 14 | 1 | 5 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.1% | +11.9% |
| Dividend StreakConsecutive years of raises | — | 1 | 0 | 2 | 5 |
| Dividend / ShareAnnual DPS | — | — | — | $0.08 | $1.29 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | +1.4% | 0.0% | 0.0% | +1.3% |
RILY leads in 1 of 6 categories (Income & Cash Flow). LQDT leads in 1 (Profitability & Efficiency). 2 tied.
SURG vs LQDT vs RILY vs GSAT vs SPOK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or LQDT or RILY or GSAT or SPOK a better buy right now?
For growth investors, Liquidity Services, Inc.
(LQDT) is the stronger pick with 31. 2% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). BRC Group Holdings, Inc. (RILY) offers the better valuation at 1. 1x trailing P/E, making it the more compelling value choice. Analysts rate Liquidity Services, Inc. (LQDT) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or LQDT or RILY or GSAT or SPOK?
On trailing P/E, BRC Group Holdings, Inc.
(RILY) is the cheapest at 1. 1x versus Liquidity Services, Inc. at 41. 7x. On forward P/E, Spok Holdings, Inc. is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SURG or LQDT or RILY or GSAT or SPOK?
Over the past 5 years, Globalstar, Inc.
(GSAT) delivered a total return of +393. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: LQDT returned +507. 2% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or LQDT or RILY or GSAT or SPOK?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus Globalstar, Inc. 's 2. 08β — meaning GSAT is approximately 396% more volatile than SPOK relative to the S&P 500. On balance sheet safety, Spok Holdings, Inc. (SPOK) carries a lower debt/equity ratio of 5% versus 151% for Globalstar, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or LQDT or RILY or GSAT or SPOK?
By revenue growth (latest reported year), Liquidity Services, Inc.
(LQDT) is pulling ahead at 31. 2% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: BRC Group Holdings, Inc. grew EPS 129. 9% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, GSAT leads at 26. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or LQDT or RILY or GSAT or SPOK?
BRC Group Holdings, Inc.
(RILY) is the more profitable company, earning 29. 8% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 29. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RILY leads at 14. 6% versus -68. 6% for SURG. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or LQDT or RILY or GSAT or SPOK more undervalued right now?
On forward earnings alone, Spok Holdings, Inc.
(SPOK) trades at 16. 4x forward P/E versus 24. 3x for Liquidity Services, Inc. — 7. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPOK: 38. 5% to $15. 00.
08Which pays a better dividend — SURG or LQDT or RILY or GSAT or SPOK?
In this comparison, SPOK (11.
9% yield), GSAT (0. 1% yield) pay a dividend. SURG, LQDT, RILY do not pay a meaningful dividend and should not be held primarily for income.
09Is SURG or LQDT or RILY or GSAT or SPOK better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). Globalstar, Inc. (GSAT) carries a higher beta of 2. 08 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 3%, GSAT: +201. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and LQDT and RILY and GSAT and SPOK?
These companies operate in different sectors (SURG (Technology) and LQDT (Consumer Cyclical) and RILY (Financial Services) and GSAT (Communication Services) and SPOK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; LQDT is a small-cap high-growth stock; RILY is a small-cap deep-value stock; GSAT is a mid-cap quality compounder stock; SPOK is a small-cap deep-value stock. SPOK pays a dividend while SURG, LQDT, RILY, GSAT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.